Dangerous Drug Case Evaluation
Note: fields with a * are required.
An attorney client relationship is not established by submitting this initial contact information to our office.
Note: fields with a * are required.
An attorney client relationship is not established by submitting this initial contact information to our office.
420 Lexington Ave. Suite 2750 New York, NY 10170 P: 212.222.4336 F: 212.953.4308 E-mail: wrs@wrslaw.com
Recent Pharmaceutical Injury News
03/18/2011 - Topamax Increases Risk of Oral Cleft Defects in Infants
05/18/2009 - Defective Drug Raptiva Recalled for Dangerous Side Effects
05/02/2009 - Popular Weight Loss Supplement Hydroxycut Recalled
Social Networking